These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 19474307)

  • 21. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
    Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
    J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain Region-Specific Trafficking of the Dopamine Transporter.
    Block ER; Nuttle J; Balcita-Pedicino JJ; Caltagarone J; Watkins SC; Sesack SR; Sorkin A
    J Neurosci; 2015 Sep; 35(37):12845-58. PubMed ID: 26377471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine and amphetamine rapidly increase dopamine transporter trafficking to the surface: live-cell imaging using total internal reflection fluorescence microscopy.
    Furman CA; Chen R; Guptaroy B; Zhang M; Holz RW; Gnegy M
    J Neurosci; 2009 Mar; 29(10):3328-36. PubMed ID: 19279270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding.
    Moritz AE; Foster JD; Gorentla BK; Mazei-Robison MS; Yang JW; Sitte HH; Blakely RD; Vaughan RA
    J Biol Chem; 2013 Jan; 288(1):20-32. PubMed ID: 23161550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitor mechanisms in the S1 binding site of the dopamine transporter defined by multi-site molecular tethering of photoactive cocaine analogs.
    Krout D; Pramod AB; Dahal RA; Tomlinson MJ; Sharma B; Foster JD; Zou MF; Boatang C; Newman AH; Lever JR; Vaughan RA; Henry LK
    Biochem Pharmacol; 2017 Oct; 142():204-215. PubMed ID: 28734777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding.
    Challasivakanaka S; Zhen J; Smith ME; Reith MEA; Foster JD; Vaughan RA
    J Biol Chem; 2017 Nov; 292(46):19066-19075. PubMed ID: 28939767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent.
    Boudanova E; Navaroli DM; Melikian HE
    Neuropharmacology; 2008 Mar; 54(3):605-12. PubMed ID: 18164041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase C-mediated functional regulation of dopamine transporter is not achieved by direct phosphorylation of the dopamine transporter protein.
    Chang MY; Lee SH; Kim JH; Lee KH; Kim YS; Son H; Lee YS
    J Neurochem; 2001 May; 77(3):754-61. PubMed ID: 11331404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocation.
    Dehnes Y; Shan J; Beuming T; Shi L; Weinstein H; Javitch JA
    Neurochem Int; 2014 Jul; 73():4-15. PubMed ID: 24576496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain.
    Lee FJ; Pristupa ZB; Ciliax BJ; Levey AI; Niznik HB
    J Biol Chem; 1996 Aug; 271(34):20885-94. PubMed ID: 8702845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport.
    Fog JU; Khoshbouei H; Holy M; Owens WA; Vaegter CB; Sen N; Nikandrova Y; Bowton E; McMahon DG; Colbran RJ; Daws LC; Sitte HH; Javitch JA; Galli A; Gether U
    Neuron; 2006 Aug; 51(4):417-29. PubMed ID: 16908408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel tropane-based irreversible ligands for the dopamine transporter.
    Zou MF; Kopajtic T; Katz JL; Wirtz S; Justice JB; Newman AH
    J Med Chem; 2001 Dec; 44(25):4453-61. PubMed ID: 11728190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Labeling of dopamine transporter transmembrane domain 1 with the tropane ligand N-[4-(4-azido-3-[125I]iodophenyl)butyl]-2beta-carbomethoxy-3beta-(4-chlorophenyl)tropane implicates proximity of cocaine and substrate active sites.
    Parnas ML; Gaffaney JD; Zou MF; Lever JR; Newman AH; Vaughan RA
    Mol Pharmacol; 2008 Apr; 73(4):1141-50. PubMed ID: 18216182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems.
    Hall FS; Itokawa K; Schmitt A; Moessner R; Sora I; Lesch KP; Uhl GR
    Neuropharmacology; 2014 Jan; 76 Pt A(0 0):146-55. PubMed ID: 23978383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluctuation of the dopamine uptake inhibition potency of cocaine, but not amphetamine, at mammalian cells expressing the dopamine transporter.
    Ukairo OT; Ramanujapuram S; Surratt CK
    Brain Res; 2007 Feb; 1131(1):68-76. PubMed ID: 17169338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin-dependent kinase 5 inhibitors: inhibition of dopamine transporter activity.
    Price DA; Sorkin A; Zahniser NR
    Mol Pharmacol; 2009 Oct; 76(4):812-23. PubMed ID: 19628755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation.
    Sakrikar D; Mazei-Robison MS; Mergy MA; Richtand NW; Han Q; Hamilton PJ; Bowton E; Galli A; Veenstra-Vanderweele J; Gill M; Blakely RD
    J Neurosci; 2012 Apr; 32(16):5385-97. PubMed ID: 22514303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Fluorescent Ligands Enable Single-Molecule Localization Microscopy of the Dopamine Transporter.
    Guthrie DA; Klein Herenbrink C; Lycas MD; Ku T; Bonifazi A; DeVree BT; Mathiasen S; Javitch JA; Grimm JB; Lavis L; Gether U; Newman AH
    ACS Chem Neurosci; 2020 Oct; 11(20):3288-3300. PubMed ID: 32926777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular model of the neural dopamine transporter.
    Ravna AW; Sylte I; Dahl SG
    J Comput Aided Mol Des; 2003; 17(5-6):367-82. PubMed ID: 14635728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine uptake and cocaine binding mechanisms: the involvement of charged amino acids from the transmembrane domains of the human dopamine transporter.
    Dar DE; Metzger TG; Vandenbergh DJ; Uhl GR
    Eur J Pharmacol; 2006 May; 538(1-3):43-7. PubMed ID: 16674939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.